trial

Clinical and Biological Characteristics of Psychotic Depression

NCTId NCT00576095
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
Phase — · Completed
Enrollment 73 (actual)
Sponsored by Stanford University
Primary completion 2012-06
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
73 (actual)
Study type
Observational
Allocation
—
Model
—
Masking
—
Start
2005-08
Primary completion
2012-06
Eligibility
ALL · 18 Years · 85 Years

Interventions & indications

Drugs
—

Sponsors

Stanford UniversityLead Sponsor
National Institutes of Health (NIH)Collaborator

Investigators

2
Alan F Schatzberg, MDPrincipal Investigator
Jennifer KellerPrincipal Investigator

Sites

1 total
Stanford, United States

Facts & assertions

4 sourced
Enrollment
73
Phase
NA
Primary Completion Date
2012-06
Status
COMPLETED
relationships
The graph out of here
lead_sponsor
Stanford University
company
collaborator
National Institutes of Health (NIH)
company
indication
Psychotic Disorders
indication
Depression
indication
Depressive Disorder, Major
indication
investigator
Alan F Schatzberg, MD
person
Jennifer Keller
person